Literature DB >> 21433308

Sp1 upregulates survivin expression in adenocarcinoma of lung cell line A549.

Yuqing Chen1, Xiaojing Wang, Wei Li, Hailong Zhang, Chengling Zhao, Yan Li, Zhenhuan Wang, Changjie Chen.   

Abstract

Survivin has been implicated in tumor genesis, progression, and resistance to anticancer agents. However, the precise regulatory mechanism for survivin expression is not thoroughly defined. In this study, we showed that Sp1 was co-overexpressed with survivin in adenocarcinoma of lung cells A549, but not in differentiated human bronchial epithelial cells 4F0439 or small airway epithelial cells 3F1584. Subsequently, transfection experiments demonstrated that the inhibition of Sp1 signaling suppressed survivin expression in A549 cells, whereas Sp1 overexpression increased the level of survivin protein as well as its mRNA. We also found that Sp1 could decrease capase-9 activity, which is shown to be suppressed by survivin during apoptosis inhibition. Finally, Luciferase activity and ChIP assays revealed that Sp1 activated survivin promoter by direct interaction with it. Taken together, our data suggest Sp1 plays a potent role in the upregulation of survivin expression in lung cancer cells at the transcriptional level.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21433308     DOI: 10.1002/ar.21378

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  11 in total

Review 1.  Epigenetic mechanism of survivin dysregulation in human cancer.

Authors:  Hui Lyu; Jingcao Huang; Zhimin He; Bolin Liu
Journal:  Sci China Life Sci       Date:  2018-01-04       Impact factor: 6.038

2.  Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.

Authors:  Shruti Patil; Umesh T Sankpal; Myrna Hurtado; W Paul Bowman; Jeffrey Murray; Kathleen Borgmann; Anuja Ghorpade; Robert Sutphin; Don Eslin; Riyaz Basha
Journal:  Gene       Date:  2019-04-13       Impact factor: 3.688

3.  Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.

Authors:  Shufeng Li; Qiwei Wang; Qian Qiang; Haitao Shan; Minke Shi; Baojun Chen; Sheng Zhao; Liudi Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-16       Impact factor: 4.553

4.  Anti-leukemic response of a NSAID, tolfenamic acid.

Authors:  Robert M Sutphin; Sarah F Connelly; Chris M Lee; Umesh T Sankpal; Don Eslin; Moeez Khan; Hima Pius; Riyaz Basha
Journal:  Target Oncol       Date:  2013-04-23       Impact factor: 4.493

5.  Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin.

Authors:  Beom Seob Lee; Jaewon Oh; Sung Ku Kang; Sungha Park; Sang-Hak Lee; Donghoon Choi; Ji Hyung Chung; Youn Wook Chung; Seok-Min Kang
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 6.  Survivin - biology and potential as a therapeutic target in oncology.

Authors:  Chun Hei Antonio Cheung; Chien-Chang Huang; Fang-Ying Tsai; Jane Ying-Chieh Lee; Siao Muk Cheng; Yung-Chieh Chang; Yi-Chun Huang; Shang-Hung Chen; Jang-Yang Chang
Journal:  Onco Targets Ther       Date:  2013-10-16       Impact factor: 4.147

7.  HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

Authors:  Wen-Tsung Huang; Yu-Hsuan Tsai; Shang-Hung Chen; Ching-Wen Kuo; Yao-Lung Kuo; Kuo-Ting Lee; Wen-Chung Chen; Pei Chih Wu; Chun-Yu Chuang; Siao Muk Cheng; Chun-Hui Lin; Euphemia Yee Leung; Yung-Chieh Chang; Chun Hei Antonio Cheung
Journal:  Front Pharmacol       Date:  2017-12-13       Impact factor: 5.810

8.  HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo.

Authors:  Wei Li; Yu-Qing Chen; Yuan-Bing Shen; Hong-Mei Shu; Xiao-Jing Wang; Cheng-Ling Zhao; Chang-Jie Chen
Journal:  Int J Mol Med       Date:  2013-06-04       Impact factor: 4.101

9.  Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations.

Authors:  Ahmet Yilmaz; Nehad Mohamed; Kara A Patterson; Yan Tang; Konstantin Shilo; Miguel A Villalona-Calero; Michael E Davis; Xiaoping Zhou; Wendy Frankel; Gregory A Otterson; Howard D Beall; Weiqiang Zhao
Journal:  Int J Environ Res Public Health       Date:  2014-09-12       Impact factor: 3.390

10.  Hypoxic tumor-derived exosomal circular RNA SETDB1 promotes invasive growth and EMT via the miR-7/Sp1 axis in lung adenocarcinoma.

Authors:  Li Xu; Wei-Lin Liao; Qi-Jue Lu; Peng Zhang; Ji Zhu; Ge-Ning Jiang
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-26       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.